Surgeon-performed intraoperative transoral ultrasound improves the detection of human papillomavirus-positive head and neck cancers of unknown primary

被引:0
|
作者
Garset-Zamani, Martin [1 ,2 ]
Lomholt, Anne Fog [1 ,2 ]
Charabi, Birgitte Wittenborg [1 ,2 ]
Norling, Rikke [3 ]
Dejanovic, Danijela [4 ]
Hall, Johanna Maria [4 ]
Makouei, Fatemeh [1 ,2 ]
Agander, Tina Klitmoller [5 ]
Ersboll, Annette Kjaer [6 ,7 ]
von Buchwald, Christian [1 ,2 ]
Todsen, Tobias [1 ,2 ,8 ]
机构
[1] Copenhagen Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg & Audiol, Rigshosp, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Inst Clin Med, Copenhagen DK-2200, Denmark
[3] Copenhagen Univ Hosp, Dept Radiol, Rigshosp, DK-2100 Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Nucl Med & Physiol, Rigshosp, DK-2100 Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Dept Pathol, Rigshosp, DK-2100 Copenhagen, Denmark
[6] Univ Copenhagen, Copenhagen Emergency Med Serv, DK-2100 Copenhagen, Denmark
[7] Univ Southern Denmark, Natl Inst Publ Hlth, DK-1455 Copenhagen, Denmark
[8] Copenhagen Acad Med Educ & Simulat CAMES, DK-2100 Copenhagen, Denmark
关键词
SQUAMOUS-CELL CARCINOMA; TRANSCUTANEOUS ULTRASOUND; DNA DETECTION; ORAL-CAVITY; TUMOR; MANAGEMENT; ORIGIN; CT;
D O I
10.1016/j.oraloncology.2024.107073
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Squamous cell carcinomas of unknown primary (SCCUP) are often Human Papillomavirus (HPV)-positive. Due to their small size, extensive surgical workup is required to locate the primary tumors. High-frequency transoral ultrasound (US) may provide improved visualization of these small tumors. Our study aimed to explore whether surgeon-performed intraoperative transoral US for patients with HPV-positive SCCUP could improve primary tumor detection during panendoscopy. Methods: This was a single-center, prospective diagnostic study including patients undergoing panendoscopy under general anesthesia with HPV-positive SCCUP. Preoperative MRIs, PET/CTs, and HPV DNA-testing of lymph node metastases were performed in all patients. Intraoperative transoral US was performed prior to panendoscopy. Frozen section biopsies were performed unblinded to US results, and transoral US-guided biopsies were attempted if initial biopsies were negative. Final histopathology was obtained with palatine- and/or lingual tonsillectomy if frozen section was negative. The main outcome was the primary tumor detection rate with intraoperative transoral US and panendoscopy. Results: Thirty patients were included: 24 (80 %) were men, and the median age was 60 years [range 35-79 years]. Twenty-nine primary tumors (97 %) were confirmed; 18 (62 %) and 10 (34 %) in the lingual- and palatine tonsils, respectively, and one (3 %) in the posterior oropharynx. Transoral US had a significantly higher sensitivity than panendoscopy to locate the primary tumor (93 % vs 76 %, p = 0.02), and significantly higher than pre-operative PET/CT (62 %, p = 0.002), CT (45 %, p < 0.001), and MRI (28 %, p < 0.001). Conclusions: Intraoperative transoral US during panendoscopy is a promising diagnostic tool that may improve the detection of HPV-positive SCCUP.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Global burden of human papillomavirus-positive head and neck cancers
    Chaturvedi, Anil K.
    LANCET ONCOLOGY, 2014, 15 (12): : 1282 - 1283
  • [2] E1 detection as prognosticator in human papillomavirus-positive head and neck cancers
    Vivenza, Daniela
    Lo Nigro, Cristiana
    Denaro, Nerina
    Fortunato, Mirella
    Monteverde, Martino
    FedericaTonissi
    Lattanzio, Laura
    Astesana, Valentina
    Gloghini, Annunziata
    Volpi, Chiara C.
    Russi, Elvio
    Merlano, Marco C.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2016, 31 (02): : E163 - E172
  • [3] ORAL RINSES MAY HELP DETECT HUMAN PAPILLOMAVIRUS-POSITIVE HEAD, NECK CANCERS
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2008, 139 (12): : 1588 - 1588
  • [4] Differential Regulation of the STING Pathway in Human Papillomavirus-Positive and -Negative Head and Neck Cancers
    Saulters, Emma L.
    Kennedy, Paul T.
    Carter, Rachel J.
    Alsufyani, Abdullah
    Jones, Terence M.
    Woolley, John F.
    Dahal, Lekh N.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (01): : 118 - 133
  • [5] Survival-Associated Metabolic Genes in Human Papillomavirus-Positive Head and Neck Cancers
    Prusinkiewicz, Martin A.
    Gameiro, Steven F.
    Ghasemi, Farhad
    Dodge, Mackenzie J.
    Zeng, Peter Y. F.
    Maekebay, Hanna
    Barrett, John W.
    Nichols, Anthony C.
    Mymryk, Joe S.
    CANCERS, 2020, 12 (01)
  • [6] Cervical staging by head and neck surgeon-performed ultrasound and FNAC In N plus head and neck cancer
    Ostermann, K.
    Asanau, A.
    Lang, F. J. W.
    B-ENT, 2018, 14 (01) : 7 - 15
  • [7] Management of Human Papillomavirus-Positive and Human Papillomavirus-Negative Head and Neck Cancer
    Mehra, Ranee
    Ang, K. Kian
    Burtness, Barbara
    SEMINARS IN RADIATION ONCOLOGY, 2012, 22 (03) : 194 - 197
  • [8] Unilateral Radiotherapy Treatment for p16/Human Papillomavirus-Positive Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
    Tiong, Albert
    Rischin, Danny
    Young, Richard J.
    Herschtal, Alan
    Solomon, Ben
    D'Costa, Ieta
    Fua, Tsien
    Liu, Chen
    Coleman, Andrew
    Kleid, Stephen
    Dixon, Benjamin J.
    Corry, June
    LARYNGOSCOPE, 2018, 128 (09): : 2076 - 2083
  • [9] Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers
    Pyeon, Dohun
    Newton, Nlichael A.
    Lambert, Paul F.
    den Boon, Johan A.
    Sengupta, Srikumar
    Marsit, Carmen J.
    Woodworth, Craig D.
    Connor, Joseph P.
    Haugen, Thomas H.
    Smith, Elaine M.
    Kelsey, Karl T.
    Turek, Lubomir P.
    Ahlquist, Paul
    CANCER RESEARCH, 2007, 67 (10) : 4605 - 4619
  • [10] The Key Differences between Human Papillomavirus-Positive and -Negative Head and Neck Cancers: Biological and Clinical Implications
    Powell, Steven F.
    Vu, Lexi
    Spanos, William C.
    Pyeon, Dohun
    CANCERS, 2021, 13 (20)